Skip to main content
Clinical Trials/NCT03289845
NCT03289845CompletedNot Applicable

Clinical Survey of Oticon Medical Ponto BHX Implant

Oticon Medical3 sites in 1 country36 target enrollmentStarted: November 5, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
36
Locations
3
Primary Endpoint
Implant stability quotient (ISQ) at surgery

Study Overview

Brief Summary

Investigation of stability of the BHX implant in adult patients indicated and counselled for a bone anchored hearing aid system. Patients are followed according to clinical practice for a total of 12 months in the study. Stability of the implant is evaluated by implant stability quotient.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients eligible for treatment with a bone anchored hearing aid
  • 18 years or older

Exclusion Criteria

  • Inability to participate in follow-up
  • Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.

Outcomes

Primary Outcomes

Implant stability quotient (ISQ) at surgery

Time Frame: At surgery

Initial implant stability measured directly after surgery

Secondary Outcomes

  • Surgical torque setting measured in Ncm(At surgery)
  • Implant stability quotient (ISQ) after 12 months of follow up(12 months post surgery)
  • Implant survivability measured as percentage successful implants after 12 months(12 months post surgery)
  • Possibility to fit the sound processor, yes/no(5-12 days post surgery)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials